Both Mounjaro (tirzepatide) and Ozempic (semaglutide) are currently approved to help control blood glucose (sugar) levels in patients withtype 2 diabetes, when used in addition to a diet plan and regular exercise. Ozempic is also approved to reduce the risk of major cardiovascular events (like...
Ozempic is also approved toreduce the risk of major cardiovascular events(like a stroke or heart attack) in adults with type 2 diabetes mellitus and established cardiovascular disease. Wegovy and Zepbound are both approved as an adjunct to diet and exercise for chronic weight management in adults ...
Bottom Line Ozempic (semaglutide) is a prescription medicine used to treat high glucose (blood sugar) levels in people with type 2 diabetes, in addition to a healthy diet and increased activity. It's also approved to reduce the risk of major adverse cardiovascular events such as heart attack,...